Global Neurology Academy

The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.

For more information about GNA, visit www.globalneurologyacademy.org.

393

LikeLikedUnlike

Episodes 16-30 of 106

MS Management: Strategies for Ensuring Equitable Access to Teleneurology
On the Frontlines of Multiple Sclerosis
MS Management: Strategies for Ensuring Equitable Access to Teleneurology
- Marisa McGinley, DO
  Peer
Aging and Multiple Sclerosis: Insights from the 2024 CMSC Consensus Statement
On the Frontlines of Multiple Sclerosis
Aging and Multiple Sclerosis: Insights from the 2024 CMSC Consensus Statement
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Yinan Zhang, MD
  Peer
- Sarah A. Morrow, MD, MS, FRCPC, FAAN
  Peer
Optimizing Schizophrenia Care: Strategies for Managing Side Effects and Treatment Resistance
On the Frontlines of Schizophrenia
Optimizing Schizophrenia Care: Strategies for Managing Side Effects and Treatment Resistance
- Joseph F. Goldberg, MD
  Peer
Understanding Schizophrenia: Early Intervention and Prevention Strategies
On the Frontlines of Schizophrenia
Understanding Schizophrenia: Early Intervention and Prevention Strategies
- Joseph F. Goldberg, MD
  Peer
Studying Cortical Lesions in MS: Future Research Directions
NeuroFrontiers
Studying Cortical Lesions in MS: Future Research Directions
- Michael G. Dwyer, PhD
  Peer
Unraveling the Mechanism: How Ocrelizumab Impacts Cortical Lesions in MS
NeuroFrontiers
Unraveling the Mechanism: How Ocrelizumab Impacts Cortical Lesions in MS
- Michael G. Dwyer, PhD
  Peer
advertisement
Reducing Cortical Lesions in MS with Ocrelizumab: Results from the ORATORI Study
NeuroFrontiers
Reducing Cortical Lesions in MS with Ocrelizumab: Results from the ORATORI Study
- Michael G. Dwyer, PhD
  Peer
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
NeuroFrontiers
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
- Jennie Taylor, MD
  Peer
Climate Change in the Clinic: Examining Neurological Impacts
NeuroFrontiers
Climate Change in the Clinic: Examining Neurological Impacts
- Beth Ann Malow, MD, MS
  Peer
mIDH Gliomas Explained: Characteristics and Management Strategies
NeuroFrontiers
mIDH Gliomas Explained: Characteristics and Management Strategies
- Jennie Taylor, MD
  Peer
Optimizing TK2d Care Through a Multidisciplinary Approach
NeuroFrontiers
Optimizing TK2d Care Through a Multidisciplinary Approach
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Kaitlin Batley, MD
  Peer
- Esra Caylan, MD
  Peer
Decoding CIDP: Pathogenesis, Diagnosis, and Clinical Clues
On the Frontlines of CIDP
Decoding CIDP: Pathogenesis, Diagnosis, and Clinical Clues
- Hans Katzberg, MD
  Peer
advertisement
Evolving Strategies in CIDP Care: Personalized Approaches and Emerging Treatments
On the Frontlines of CIDP
Evolving Strategies in CIDP Care: Personalized Approaches and Emerging Treatments
- Sami Khella, MD
  Peer
Understanding CIDP: A Roadmap to Diagnosis
On the Frontlines of CIDP
Understanding CIDP: A Roadmap to Diagnosis
- Sami Khella, MD
  Peer
Investigating Gene Therapy for DMD: The Role of Caregiver-Reporter Scales
NeuroFrontiers
Investigating Gene Therapy for DMD: The Role of Caregiver-Reporter Scales
- Craig M. McDonald, MD
  Peer